Christopher C. Riedl

3.7k total citations
62 papers, 2.5k citations indexed

About

Christopher C. Riedl is a scholar working on Radiology, Nuclear Medicine and Imaging, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Christopher C. Riedl has authored 62 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Radiology, Nuclear Medicine and Imaging, 18 papers in Cancer Research and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Christopher C. Riedl's work include Medical Imaging Techniques and Applications (17 papers), Breast Cancer Treatment Studies (14 papers) and Breast Lesions and Carcinomas (13 papers). Christopher C. Riedl is often cited by papers focused on Medical Imaging Techniques and Applications (17 papers), Breast Cancer Treatment Studies (14 papers) and Breast Lesions and Carcinomas (13 papers). Christopher C. Riedl collaborates with scholars based in United States, Austria and Italy. Christopher C. Riedl's co-authors include Thomas H. Helbich, Gary A. Ulaner, Katja Pinker, Wolfgang Weber, Margaretha Rudas, Michael Weber, Daniel L.J. Thorek, Jan Grimm, Komal Jhaveri and Yuman Fong and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Clinical Cancer Research.

In The Last Decade

Christopher C. Riedl

59 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher C. Riedl United States 27 1.4k 766 731 513 512 62 2.5k
Kenneth J. Bloom United States 22 662 0.5× 889 1.2× 1.5k 2.0× 484 0.9× 572 1.1× 42 2.6k
Francis R. Spitz United States 25 308 0.2× 530 0.7× 1.1k 1.5× 413 0.8× 522 1.0× 55 2.4k
Carolien H. M. van Deurzen Netherlands 32 415 0.3× 1.6k 2.1× 1.3k 1.8× 377 0.7× 1.0k 2.0× 108 3.3k
Timothy Akhurst United States 35 1.4k 1.0× 282 0.4× 1.9k 2.7× 1.4k 2.7× 137 0.3× 75 4.4k
Roel Mus Netherlands 20 1.2k 0.9× 284 0.4× 437 0.6× 187 0.4× 488 1.0× 31 2.0k
Rastko Golouh Slovenia 32 488 0.4× 1.7k 2.2× 2.0k 2.7× 474 0.9× 719 1.4× 79 3.8k
Elzbieta Slodkowska Canada 24 703 0.5× 669 0.9× 1.2k 1.6× 315 0.6× 291 0.6× 65 2.1k
Lawrence H. Schwartz United States 21 774 0.6× 209 0.3× 963 1.3× 733 1.4× 311 0.6× 36 2.3k
José Miguel Esteban López-Jamar Spain 32 907 0.7× 511 0.7× 1.1k 1.5× 797 1.6× 304 0.6× 95 3.5k
Christina S. Kong United States 35 369 0.3× 731 1.0× 1.6k 2.2× 737 1.4× 341 0.7× 124 4.3k

Countries citing papers authored by Christopher C. Riedl

Since Specialization
Citations

This map shows the geographic impact of Christopher C. Riedl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Riedl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Riedl more than expected).

Fields of papers citing papers by Christopher C. Riedl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Riedl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Riedl. The network helps show where Christopher C. Riedl may publish in the future.

Co-authorship network of co-authors of Christopher C. Riedl

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Riedl. A scholar is included among the top collaborators of Christopher C. Riedl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Riedl. Christopher C. Riedl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deipolyi, Amy R., Christopher Johnson, Christopher C. Riedl, et al.. (2022). Prospective Evaluation of Immune Activation Associated with Response to Radioembolization Assessed with PET/CT in Women with Breast Cancer Liver Metastasis. Radiology. 306(1). 279–287. 13 indexed citations
2.
Young, Robert J., Paula Demétrio De Souza França, Giacomo Pirovano, et al.. (2020). Preclinical and first-in-human-brain-cancer applications of [18F]poly (ADP-ribose) polymerase inhibitor PET/MR. Neuro-Oncology Advances. 2(1). vdaa119–vdaa119. 26 indexed citations
3.
Ulaner, Gary A., Jorge A. Carrasquillo, Christopher C. Riedl, et al.. (2020). Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted 89Zr-Pertuzumab PET/CT. Radiology. 296(2). 370–378. 45 indexed citations
4.
Das, Jeeban Paul, Christopher C. Riedl, & Gary A. Ulaner. (2020). 18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor. Clinical Nuclear Medicine. 45(12). 989–991.
5.
Marino, Maria Adele, et al.. (2019). Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools. The Oncologist. 25(2). e231–e242. 135 indexed citations
6.
Deipolyi, Amy R., Ryan W. England, Fourat Ridouani, et al.. (2019). PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer. CardioVascular and Interventional Radiology. 43(3). 488–494. 11 indexed citations
7.
Kirchner, Julian, Christopher C. Riedl, & Gary A. Ulaner. (2019). Patient Repositioning Reveals a Malignant Pleura Effusion Initially Mistaken as a Bone Metastasis on 18FDG PET/CT. Clinical Nuclear Medicine. 44(12). 969–970.
8.
Ulaner, Gary A., et al.. (2018). 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men. Journal of Nuclear Medicine. 60(4). 472–477. 8 indexed citations
9.
Ulaner, Gary A., Serge K. Lyashchenko, Christopher C. Riedl, et al.. (2017). First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer. Journal of Nuclear Medicine. 59(6). 900–906. 141 indexed citations
10.
Houssami, Nehmat, Maartje J. Hooning, Christopher C. Riedl, et al.. (2017). Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis. European Journal of Cancer. 85. 31–38. 22 indexed citations
11.
Pinker, Katja, Christopher C. Riedl, & Wolfgang Weber. (2017). Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments. European Journal of Nuclear Medicine and Molecular Imaging. 44(S1). 55–66. 116 indexed citations
12.
Pinker, Katja, Christopher C. Riedl, Maxine S. Jochelson, et al.. (2016). The Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST. Journal of Nuclear Medicine. 57(7). 1102–1104. 26 indexed citations
13.
Saadatmand, Sepideh, Geertruida H. de Bock, Ellen Warner, et al.. (2016). Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. British Journal of Cancer. 114(6). 631–637. 72 indexed citations
14.
Thorek, Daniel L.J., Christopher C. Riedl, & Jan Grimm. (2013). Clinical Cerenkov Luminescence Imaging of18F-FDG. Journal of Nuclear Medicine. 55(1). 95–98. 124 indexed citations
15.
Reiner, Caecilia S., Thomas H. Helbich, Margaretha Rudas, et al.. (2009). Can galactography-guided stereotactic, 11-gauge, vacuum-assisted breast biopsy of intraductal lesions serve as an alternative to surgical biopsy?. European Radiology. 19(12). 2878–2885. 6 indexed citations
16.
Lin, Shu‐Fu, Zhenkun Yu, Christopher C. Riedl, et al.. (2007). Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery. 142(6). 976–983. 43 indexed citations
17.
Riedl, Christopher C., Peter Brader, Pat Zanzonico, et al.. (2007). Tumor hypoxia imaging in orthotopic liver tumors and peritoneal metastasis: a comparative study featuring dynamic 18F-MISO and 124I-IAZG PET in the same study cohort. European Journal of Nuclear Medicine and Molecular Imaging. 35(1). 39–46. 29 indexed citations
18.
Adusumilli, Prasad S., David P. Eisenberg, Yun Shin Chun, et al.. (2005). Virally Directed Fluorescent Imaging Improves Diagnostic Sensitivity in the Detection of Minimal Residual Disease After Potentially Curative Cytoreductive Surgery. Journal of Gastrointestinal Surgery. 9(8). 1138–1147. 18 indexed citations
19.
Riedl, Christopher C., et al.. (2004). Der Stellenwert der ALA-(5-Amino-Lävulinsäure)-Fluoreszenzdetektion für die Prognose des oberflächlichen Blasenkarzinoms. Aktuelle Urologie. 35(6). 497–501. 3 indexed citations
20.
Riedl, Christopher C., Georg Pfarl, Thomas H. Helbich, et al.. (2002). Vergleich Häkchen versus Kohlefarbstoff bei präoperativer Markierung von nicht-tastbaren Brustläsionen. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 174(9). 1126–1131. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth J. Bloom Breakdown of academic impact, for papers by Francis R. Spitz Breakdown of academic impact, for papers by Carolien H. M. van Deurzen Breakdown of academic impact, for papers by Timothy Akhurst Breakdown of academic impact, for papers by Roel Mus Breakdown of academic impact, for papers by Rastko Golouh Breakdown of academic impact, for papers by Elzbieta Slodkowska Breakdown of academic impact, for papers by Lawrence H. Schwartz Breakdown of academic impact, for papers by José Miguel Esteban López-Jamar Breakdown of academic impact, for papers by Christina S. Kong
Rankless by CCL
2026